Barinthus Biotherapeutics (BRNS) Free Cash Flow Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 60.84% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 88.70% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.72% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 66.37% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.78 Mn | -39.33 Mn | - | 77.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.42% |
| Dec 31, 2025 | -133.12% |
| Sep 30, 2025 | 41.43% |
| Jun 30, 2025 | -48.72% |
| Mar 31, 2025 | -22.89% |
| Dec 31, 2024 | 190.68% |
| Sep 30, 2024 | -12.68% |
| Jun 30, 2024 | 19.83% |
| Mar 31, 2024 | -123.76% |
| Dec 31, 2023 | -18.40% |
| Sep 30, 2023 | -301.85% |
| Jun 30, 2023 | -68.69% |
| Mar 31, 2023 | 29.33% |
| Dec 31, 2022 | -42.08% |
| Sep 30, 2022 | 394.91% |
| Jun 30, 2022 | 36.67% |
| Mar 31, 2022 | 8.25% |
| Dec 31, 2021 | -64.92% |
| Sep 30, 2021 | -606.49% |
| Jun 30, 2021 | -487.06% |